DOD, Tuberous Sclerosis Complex Research Program, Idea Development Award

The summary for the DOD, Tuberous Sclerosis Complex Research Program, Idea Development Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DOD, Tuberous Sclerosis Complex Research Program, Idea Development Award: The Idea Development Award promotes ideas that have the potential to yield high-impact findings and new avenues of investigation. This award mechanism supports conceptually innovative research that could ultimately lead to critical discoveries in TSC research and/or improvements in patient care. Research projects should include a well-formulated, testable hypothesis based on strong preliminary data and scientific rationale.The following are important aspects of the Idea Development Award:Impact: Applications should articulate both the short- and long-term impact of the proposed research. High-impact research will, if successful, significantly advance TSC research and/or patient care.Innovation: Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities that may include high-risk/potentially high-gain approaches to TSC research. Research that is merely an incremental advance (the next logical step) is not considered innovative.Although not all-inclusive, the following examples are ways in which the proposed research project may be innovative:-Explores a novel idea and/or research question in TSC research and/or patient care.-Uses or develops novel methods or technologies to address a question in TSC research and/or patient care.-Applies or adapts existing methods or technologies for novel TSC research or clinical purposes that differ fundamentally from those originally intended.Preliminary Data: Unpublished results from the laboratory of the Principal Investigator (PI) or collaborators named on this application, and/or data from the published literature that are relevant to TSC and the proposed research project, are expected.New-to-the-Field Investigator: The FY22 TSCRP Idea Development Award mechanism encourages applications from investigators in the early stages of their TSC research career. The New-to-the-Field Investigator Option is designed to support the continued development of promising independent investigators that are early in their faculty appointments and/or the transition of established investigators from other research fields into a career in the field of TSC research. Applications to the New-to-the-Field Investigator Option will compete separately from Established Investigators submitting to the regular Idea Development Award. PIs applying under the New-to-the-Field Investigator category are strongly encouraged to strengthen their applications through collaboration with investigators experienced in TSC research and/or possessing other relevant expertise as demonstrated by a record of funding and publications.